Evidence map›Paper›PMID 33924651›Full record

ArticleBrain sciences2021

Childhood Maltreatment and Its Interaction with Hypothalamic-Pituitary-Adrenal Axis Activity and the Remission Status of Major Depression: Effects on Functionality and Quality of Life.

Neus Salvat-Pujol, Javier Labad, Mikel Urretavizcaya, Aida De Arriba-Arnau, Cinto Segalàs, Eva Real, Alex Ferrer, José Manuel Crespo, Susana Jiménez-Murcia, Carles Soriano-Mas and 2 more

Abstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Neus Salvat-PujolNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0001-5320-331X
Javier LabadCentro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Carlos III Health Institute, 28029 Madrid, Spain.ORCID 0000-0003-2214-1886
Mikel UrretavizcayaNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0002-9746-4068
Aida De Arriba-ArnauNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0002-7877-7341
Cinto SegalàsNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
Eva RealNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
Alex FerrerNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
José Manuel CrespoNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
Susana Jiménez-MurciaNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0002-3596-8033
Carles Soriano-MasNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0003-4574-6597
José Manuel MenchónNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.
Virginia SoriaNeurosciences Group-Psychiatry and Mental Health, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Department of Psychiatry, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0001-6412-6831

Funding

Departament de Salut, Generalitat de Catalunya AGAUR 2017 SGR 1247Departament de Salut, Generalitat de Catalunya SLT006/17/00012Instituto de Salud Carlos III CP10/00604Instituto de Salud Carlos III INT19/00071Instituto de Salud Carlos III JR14/00038Instituto de Salud Carlos III PI10/01753Instituto de Salud Carlos III PI15/00662Instituto de Salud Carlos III PI19/01040Instituto de Salud Carlos III PT17/0015/0024
6 · The paper itself

Abstract

Relationships among childhood maltreatment (CM), hypothalamic-pituitary-adrenal (HPA) axis disturbances, major depressive disorder (MDD), poor functionality, and lower quality of life (QoL) in adulthood have been described. We aimed to study the roles of the remission status of depression and HPA axis function in the relationships between CM and functionality and QoL. Ninety-seven patients with MDD and 97 healthy controls were included. The cortisol awakening response, cortisol suppression ratio in the dexamethasone suppression test, and diurnal cortisol slope were assessed. Participants completed measures of psychopathology, CM, functionality, and QoL. Multiple linear regression analyses were performed to study the relationships between CM and functionality and QoL. Only non-remitted MDD patients showed lower functionality and QoL than controls, indicating that depressive symptoms may partly predict functionality and QoL. Cortisol measures did not differ between remitted and non-remitted patients. Although neither HPA axis measures nor depression remission status were consistently associated with functionality or QoL, these factors moderated the effects of CM on functionality and QoL. In conclusion, subtle neurobiological dysfunctions in stress-related systems could help to explain diminished functionality and QoL in individuals with CM and MDD and contribute to the persistence of these impairments even after the remission of depressive symptoms.

Indexed as

childhood maltreatmentcortisolfunctionalitymajor depressive disorderquality of life

Identifiers

PMID33924651
PMCPMC8069655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.